Skip to main content

Find Clinical Trials

Clinical trial condition

HIV-1

Explore clinical trials studying HIV-1. Study availability and eligibility vary by location and protocol.

66 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

HIV-1 trial results

Completed

A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents

NCT00355524

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Los Angeles, California, United States

Washington D.C., District of Columbia, United States

Chicago, Illinois, United States

Boston, Massachusetts, United States

View all 22 locations

View Trial Details

Completed

Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1

NCT00807443

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Hospital Universitario Ramon Y Cajal Madrid, Spain

View Trial Details

Completed

Non-Interventional Study Of Celsentri® In Treatment Experienced Patients With CCR5-Tropic HIV-Infection

NCT00850395

Conditions: HIV-1
Locations: Not specified

View Trial Details

Completed

Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects

NCT01084343

Conditions: HIV-1
Locations: CEVAC Ghent, Belgium

View Trial Details

Completed

Fuzeon Viral Decay Pilot Study

NCT00334022

Conditions: HIV-1
Locations: Maple Leaf Medical Clinic Toronto, Ontario, Canada

View Trial Details

Completed

Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers

NCT00982579

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Medical Research Council Laboratories, The Gambia Banjul, Fajara, The Gambia

View Trial Details

Completed

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial

NCT00772902

Conditions: HIV-1
Locations: Gilead Sciences Vienna, Austria

Gilead Sciences Munich, Germany

Gilead Sciences Milan, Italy

Gilead Sciences Madrid, Spain

View Trial Details

Completed

TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation

NCT00812292

Conditions: Bioavailability, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions

NCT01140139

Conditions: HIV-1
Locations: South Hospital Stockholm, Sweden

View Trial Details

Completed

TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients

NCT00412646

Conditions: Acquired Immunodeficiency Syndrome, Anti-Retroviral Agents, Blood-Borne Infections, +15 more
Locations: Not specified

View Trial Details